Zelluna ASA (OSL:ZLNA) Interest Income : kr12.42 Mil (TTM As of Dec. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Zelluna ASA Interest Income?

Interest Income is the interest earned on cash temporarily held in savings accounts, certificates of deposits, or other investments. Zelluna ASA's interest income for the three months ended in Dec. 2024 was kr1.87 Mil. Its interest income for the trailing twelve months (TTM) ended in Dec. 2024 was kr12.42 Mil.

Zelluna ASA Interest Income Historical Data

The historical data trend for Zelluna ASA's Interest Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zelluna ASA Interest Income Chart

Zelluna ASA Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Interest Income

Get a 7-Day Free Trial

4.58

3.06

8.91

14.13

8.60

Zelluna ASA Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Interest Income	Get a 7-Day Free Trial															5.61	6.26	0.82	3.46	1.87

Zelluna ASA Interest Income Calculation

Interest Income is the interest earned on cash temporarily held in savings accounts, certificates of deposits, or other investments.

Interest Income for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr12.42 Mil.

Zelluna ASA Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zelluna ASA (OSL:ZLNA) » Definitions » Interest Income

Comparable Companies

Traded in Other Exchanges

ULTIo:Sweden 7UM0:Germany

Address

Ullernchausseen 64, Oslo, NOR, 0379

Website

https://www.zelluna.com

Zelluna ASA is a clinical-stage biotechnology company developing novel immunotherapies against cancer and the development of T-Cell Receptor Natural Killer cell therapies for the treatment of solid cancers. The company's current pipeline consists of allogeneic TCR-NK R&D programs ZI-MA4-1, ZI-KL1-1, and ZI-PR-1 targeting well validated antigens expressed across a broad range of solid tumors.

Zelluna ASA Headlines

No Headlines